Global Information
회사소개 | 문의 | 비교리스트

차세대 시퀀싱(NGS) 시장 : 세계 산업 동향, 점유율, 규모, 성장률, 기회, 예측(2020-2025년)

Next-generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

리서치사 IMARC Services Private Limited
발행일 2020년 06월 상품 코드 945208
페이지 정보 영문 104 Pages
가격
US $ 2,299 ₩ 2,716,000 PDF (Single User License)
US $ 3,399 ₩ 4,016,000 PDF (5 User License)
US $ 4,499 ₩ 5,316,000 PDF (Corporate License)


차세대 시퀀싱(NGS) 시장 : 세계 산업 동향, 점유율, 규모, 성장률, 기회, 예측(2020-2025년) Next-generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025
발행일 : 2020년 06월 페이지 정보 : 영문 104 Pages

세계의 차세대 시퀀싱(NGS) 시장은 강력한 성장을 보이고 있습니다. 암과 같은 만성 내과 질환의 유병률 상승은 의학 분야에서 다양한 기술적 진보와 함께 시장의 성장을 촉진하는 주요 요인 중 하나입니다. 암진단에서 액체생검의 보급에 의해 NGS 기술의 이용이 대폭 증가하고 있습니다. 또한 다양한 질환의 발증을 예측하기 위한 게놈 지도제작 프로그램의 채택 증가도 시장의 성장을 지원하고 있습니다. 다양한 기술적 진보와 클라우드 컴퓨팅 시스템과의 통합에 의해 데이터 관리가 개선되며 시장의 성장에 플러스 영향을 미치고 있습니다. NGS 시스템의 비용 하락, 시퀀스 화학, 분자생물학, 기술 공학 분야에서의 광범위한 조사 개발(R&D) 활동 등의 기타 요인도 시장을 한층 더 촉진할 것으로 예측됩니다. IMARC Group은 2020-2025년 시장이 약 17%의 CAGR을 기록할 것으로 예측하고 있습니다.

세계의 차세대 시퀀싱(NGS) 시장에 대해 조사했으며, 시장의 개요, 각 부문 및 지역별 시장 규모 예측, 주요 기업의 개요, 경쟁 구도 분석 등의 정보를 정리하여 전해드립니다.

제1장 서론

제2장 범위와 조사 방법

제3장 개요

제4장 서론

제5장 세계의 차세대 시퀀싱(NGS) 시장

  • 시장 개요
  • 시장 성과

제6장 시장 내역 : 유형별

  • 전게놈 시퀀싱
  • 타깃 리시퀀싱
  • 전엑솜 시퀀싱
  • RNA 시퀀싱
  • 크로마틴 면역 침강(ChIP) 시퀀싱
  • De novo 시퀀싱
  • 메틸화 시퀀싱
  • 기타

제7장 시장 내역 : 제품 유형별

  • 장비
  • 시약·소모품
  • 소프트웨어·서비스

제8장 시장 내역 : 기술별

  • 염기합성법(SBS)
  • 이온 반도체 시퀀싱
  • 단일 분자 실시간 시퀀싱
  • 나노포어 시퀀싱
  • 기타

제9장 시장 내역 : 애플리케이션별

  • Drug Discovery·맞춤형 의료
  • 유전자 스크리닝
  • 진단
  • 농업 및 동물 연구
  • 기타

제10장 시장 내역 : 최종사용자별

  • 학술기관·연구 센터
  • 병원·진료소
  • 의약품·바이오테크놀러지 기업
  • 기타

제11장 시장 내역 : 지역별

  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 한국
    • 호주
    • 인도네시아
    • 기타
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인
    • 러시아
    • 기타
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 기타
  • 중동과 아프리카
    • 시장 내역 : 국가별

제12장 SWOT 분석

제13장 밸류체인 분석

제14장 Porter의 산업 분석

제15장 가격 지표

제16장 경쟁 구도

  • 시장 구조
  • 주요 기업
  • 주요 기업의 개요
    • Agilent Technologies Inc.
    • Becton Dickinson and Company
    • Genomics
    • BGI Group
    • Eurofins Scientific
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • Genewiz
    • Macrogen Inc.
    • Oxford Nanopore Technologies
    • Pacific Biosciences
    • Perkinelmer Inc.
    • Thermo Fisher Scientific Inc.
    • Qiagen N.V.
    • Genapsys Inc.
KSA 20.07.09

List of Figures

  • Figure 1: Global: Next-Generation Sequencing Market: Major Drivers and Challenges
  • Figure 2: Global: Next-Generation Sequencing Market: Sales Value (in Billion US$), 2014-2019
  • Figure 3: Global: Next-Generation Sequencing Market: Breakup by Sequencing Type (in %), 2019
  • Figure 4: Global: Next-Generation Sequencing Market: Breakup by Product Type (in %), 2019
  • Figure 3: Global: Next-Generation Sequencing Market: Breakup by Technology (in %), 2019
  • Figure 4: Global: Next-Generation Sequencing Market: Breakup by Application (in %), 2019
  • Figure 5: Global: Next-Generation Sequencing Market: Breakup by End-User (in %), 2019
  • Figure 6: Global: Next-Generation Sequencing Market: Breakup by Region (in %), 2019
  • Figure 7: Global: Next-Generation Sequencing Market Forecast: Sales Value (in Billion US$), 2020-2025
  • Figure 8: Global: Next-Generation Sequencing (Whole Genome Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 9: Global: Next-Generation Sequencing (Whole Genome Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 10: Global: Next-Generation Sequencing (Targeted Resequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 11: Global: Next-Generation Sequencing (Targeted Resequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 12: Global: Next-Generation Sequencing (Whole Exome Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 13: Global: Next-Generation Sequencing (Whole Exome Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 14: Global: Next-Generation Sequencing (RNA Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 15: Global: Next-Generation Sequencing (RNA Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 16: Global: Next-Generation Sequencing (CHIP Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 17: Global: Next-Generation Sequencing (CHIP Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 18: Global: Next-Generation Sequencing (De Novo Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 19: Global: Next-Generation Sequencing (De Novo Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 20: Global: Next-Generation Sequencing (Methyl Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 21: Global: Next-Generation Sequencing (Methyl Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 22: Global: Next-Generation Sequencing (Other Types) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 23: Global: Next-Generation Sequencing (Other Types) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 24: Global: Next-Generation Sequencing (Instruments) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 25: Global: Next-Generation Sequencing (Instruments) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 26: Global: Next-Generation Sequencing (Reagents and Consumables) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 27: Global: Next-Generation Sequencing (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 28: Global: Next-Generation Sequencing (Software and Services) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 29: Global: Next-Generation Sequencing (Software and Services) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 20: Global: Next-Generation Sequencing (Sequencing by Synthesis) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 21: Global: Next-Generation Sequencing (Sequencing by Synthesis) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 22: Global: Next-Generation Sequencing (Ion Semiconductor Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 23: Global: Next-Generation Sequencing (Ion Semiconductor Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 24: Global: Next-Generation Sequencing (Single-Molecule Real-Time Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 25: Global: Next-Generation Sequencing (Single-Molecule Real-Time Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 26: Global: Next-Generation Sequencing (Nanopore Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 27: Global: Next-Generation Sequencing (Nanopore Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 28: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 29: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 20: Global: Next-Generation Sequencing (Drug Discovery and Personalized Medicine) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 21: Global: Next-Generation Sequencing (Drug Discovery and Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 22: Global: Next-Generation Sequencing (Genetic Screening) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 23: Global: Next-Generation Sequencing (Genetic Screening) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 24: Global: Next-Generation Sequencing (Diagnostics) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 25: Global: Next-Generation Sequencing (Diagnostics) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 26: Global: Next-Generation Sequencing (Agriculture and Animal Research) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 27: Global: Next-Generation Sequencing (Agriculture and Animal Research) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 28: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 29: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 22: Global: Next-Generation Sequencing (Academic Institutes & Research Centers) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 23: Global: Next-Generation Sequencing (Academic Institutes & Research Centers) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 24: Global: Next-Generation Sequencing (Hospitals & Clinics) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 25: Global: Next-Generation Sequencing (Hospitals & Clinics) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 26: Global: Next-Generation Sequencing (Pharmaceutical & Biotechnology Companies) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 27: Global: Next-Generation Sequencing (Pharmaceutical & Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 28: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 29: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 30: North America: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 31: North America: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 32: United States: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 33: United States: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 34: Canada: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 35: Canada: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 36: Asia Pacific: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 37: Asia Pacific: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 38: China: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 39: China: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 40: Japan: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 41: Japan: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 42: India: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 43: India: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 44: South Korea: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 45: South Korea: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 46: Australia: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 47: Australia: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 48: Indonesia: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 49: Indonesia: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 50: Others: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 51: Others: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 52: Europe: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 53: Europe: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 54: Germany: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 55: Germany: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 56: France: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 57: France: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 58: United Kingdom: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 59: United Kingdom: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 60: Italy: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 61: Italy: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 62: Spain: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 63: Spain: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 64: Russia: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 65: Russia: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 66: Others: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 67: Others: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 68: Latin America: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 69: Latin America: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 70: Brazil: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 71: Brazil: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 72: Mexico: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 73: Mexico: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 74: Others: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 75: Others: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 76: Middle East and Africa: Next Generation Sequencing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 77: Middle East and Africa: Next Generation Sequencing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 78: Global: Next-Generation Sequencing Industry: SWOT Analysis
  • Figure 79: Global: Next-Generation Sequencing Industry: Value Chain Analysis
  • Figure 80: Global: Next-Generation Sequencing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Next-Generation Sequencing Market: Key Industry Highlights, 2019 and 2025
  • Table 2: Global: Next-Generation Sequencing Market Forecast: Breakup by Product Type (in Million US$), 2020-2025
  • Table 3: Global: Next-Generation Sequencing Market Forecast: Breakup by Sequencing Type (in Million US$), 2020-2025
  • Table 4: Global: Next-Generation Sequencing Market Forecast: Breakup by Technology (in Million US$), 2020-2025
  • Table 5: Global: Next-Generation Sequencing Market Forecast: Breakup by Application (in Million US$), 2020-2025
  • Table 6: Global: Next-Generation Sequencing Market Forecast: Breakup by End-User (in Million US$), 2020-2025
  • Table 7: Global: Next-Generation Sequencing Market Forecast: Breakup by Region (in Million US$), 2020-2025
  • Table 8: Global: Next-Generation Sequencing Market Structure
  • Table 9: Global: Next-Generation Sequencing Market: Key Players

The global next-generation sequencing (NGS) market is currently witnessing robust growth. Next-generation sequencing, or high-throughput sequencing, refers to the process of determining the sequence of nucleotides in a section of the DNA. It includes procedures such as sequencing by synthesis (SBS), ion semiconductor sequencing, nanopore sequencing and single-molecule real-time (SMRT) sequencing. It is a cost-effective solution that offers precise results with high accuracy and speed. This enables the analysis of millions of DNA molecules simultaneously, which facilitates research in the fields of personalized and genetic medicines, agriculture and animal research, and clinical diagnostics.

The increasing prevalence of chronic medical ailments, such as cancer, along with various technological advancements in the field of medical sciences, is one of the key factors driving the growth of the market. Owing to the widespread adoption of liquid biopsies in cancer diagnostics, there has been a significant increase in the utilization of NGS technologies. These technologies utilize cell-free circulating tumor DNA (ctDNA) as a non-invasive cancer biomarker for real-time cancer monitoring and detection. Furthermore, the increasing adoption of genome mapping programs to predict the development of various diseases is also providing a boost to the market growth. Genetic maps are used for guiding scientists to analyze the genes that are responsible for increasing the prevalence of diabetes, heart diseases, asthma, cancer and psychiatric conditions. Additionally, various technological advancements and integration with the cloud-computing systems for improved data management, are creating a positive impact on the market growth. Other factors, including the declining costs of NGS systems and extensive research and development (R&D) activities in the field of sequencing chemistry, molecular biology and technical engineering, are projected to drive the market further. Looking forward, IMARC Group expects the market to register a CAGR of around 17% during 2020-2025.

Breakup by Sequencing Type:

  • Whole Genome Sequencing
  • Targeted Resequencing
  • Whole Exome Sequencing
  • RNA Sequencing
  • CHIP Sequencing
  • De Novo Sequencing
  • Methyl Sequencing
  • Others

Breakup by Product Type:

  • Instruments
  • Reagents and Consumables
  • Software and Services

Breakup by Technology:

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Single-Molecule Real-Time Sequencing
  • Nanopore Sequencing
  • Others

Breakup by Application:

  • Drug Discovery and Personalized Medicine
  • Genetic Screening
  • Diagnostics
  • Agriculture and Animal Research
  • Others

Breakup by End-User:

  • Academic Institutes & Research Centers
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies, Becton Dickinson and Company, 10x Genomics, BGI Group, Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina Inc., Genewiz, Macrogen, Oxford Nanopore Technologies, Pacific Biosciences, PerkinElmer, Thermo Fisher Scientific, Qiagen N.V., GenapSys Inc., etc.

Key Questions Answered in This Report:

  • How has the global next-generation sequencing market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the market based on the sequencing type?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global next-generation sequencing market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Next-Generation Sequencing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Market Forecast

6 Market Breakup by Sequencing Type

  • 6.1 Whole Genome Sequencing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Targeted Resequencing
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Whole Exome Sequencing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 RNA Sequencing
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 CHIP Sequencing
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 De Novo Sequencing
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Methyl Sequencing
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Product Type

  • 7.1 Instruments
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Reagents and Consumables
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Software and Services
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Sequencing by Synthesis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ion Semiconductor Sequencing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Single-Molecule Real-Time Sequencing
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Nanopore Sequencing
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Drug Discovery and Personalized Medicine
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Genetic Screening
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Diagnostics
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Agriculture and Animal Research
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Academic Institutes & Research Centers
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals & Clinics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Pharmaceutical & Biotechnology Companies
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Agilent Technologies Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Becton Dickinson and Company
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 10x Genomics
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 BGI Group
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Eurofins Scientific
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 F. Hoffmann-La Roche AG
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
    • 16.3.7 Illumina Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Genewiz
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Macrogen Inc.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
    • 16.3.10 Oxford Nanopore Technologies
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Pacific Biosciences
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
    • 16.3.12 Perkinelmer Inc.
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Thermo Fisher Scientific Inc.
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials
      • 16.3.13.4 SWOT Analysis
    • 16.3.14 Qiagen N.V.
      • 16.3.14.1 Company Overview
      • 16.3.14.2 Product Portfolio
      • 16.3.14.3 Financials
      • 16.3.14.4 SWOT Analysis
    • 16.3.15 Genapsys Inc.
      • 16.3.15.1 Company Overview
      • 16.3.15.2 Product Portfolio

Back to Top
전화 문의
F A Q